title: Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphenous veins.
abstract: A fourth PGE receptor subtype, the EP4 receptor, has recently been described in the pig saphenous vein (PSV). Similar to the EP2 receptor, it mediates relaxation and is linked to stimulation of adenylate cyclase. The aim of this study was to determine whether or not the EP receptor present in the rabbit jugular vein (RJV), currently classified as an atypical EP2 receptor, is of the EP4 subtype. The relaxant activities of four EP2 agonists, 11-deoxy PGE1, 16,16-dimethyl PGE2, butaprost, and AH 13205, on the RJV and PSV have been examined, and the effect of the EP4 receptor antagonist AH 23,848B studied. The EP2 agonists showed a similar order of potency on the two preparations. 11-Deoxy PGE1 and 16,16-dimethyl PGE2 were potent agonists on the EP4 receptors of the PSV and on the RJV giving approximately equi-effective concentration ratios (EECs) of 2.0-6.6 and 2.8-9.9, respectively, compared to PGE2 (EEC = 1), and so do not discriminate between EP2 and EP4 receptors. Butaprost was less active on these preparations (EEC 42-43) than on classical EP2 receptors, and AH 13205 was much less active (EEC 3100-2780). While these results suggest that the EP receptors on the RJV are of the EP4 subtype, this was not confirmed using the EP4 receptors antagonist AH 23,848B.
authors.affiliation: Department of Pharmacology, University of Edinburgh, Scotland.
authors.forename: S A
authors.initials: SA
authors.lastname: Milne
authors.forename: R A
authors.initials: RA
authors.lastname: Armstrong
authors.forename: D F
authors.initials: DF
authors.lastname: Woodward
mesh_terms: D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology; D000527:Alprostadil / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000502:physiology; D007601:Jugular Veins / Q000502:physiology; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology; D011466:Prostanoic Acids / Q000494:pharmacology; D011817:Rabbits; D018078:Receptors, Prostaglandin E / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000502:physiology*; D012501:Saphenous Vein / Q000502:physiology; D013552:Swine
chemical_list: D001713:Biphenyl Compounds; D011461:Prostaglandins F, Synthetic; D011466:Prostanoic Acids; D018078:Receptors, Prostaglandin E; C081039:AH 13205; C048895:nocloprost; C046926:AH 23848; D000527:Alprostadil; C048491:butaprost; D015064:16,16-Dimethylprostaglandin E2; C034008:11-deoxyprostaglandin E1